BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 22555094)

  • 21. A comparability study of 5 commercial KRAS tests.
    Oliner K; Juan T; Suggs S; Wolf M; Sarosi I; Freeman DJ; Gyuris T; Baron W; Bakker A; Parker A; Patterson SD
    Diagn Pathol; 2010 Apr; 5():23. PubMed ID: 20398393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KRAS testing in clinical laboratory: optimizing targeted therapy.
    Miravalle L; Lefferts JA; Al-Haddad M; Tsongalis GJ; Cheng L
    Cancer Genomics Proteomics; 2012; 9(5):337-41. PubMed ID: 22990113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
    Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
    J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH.
    Shi SR; Cote RJ; Wu L; Liu C; Datar R; Shi Y; Liu D; Lim H; Taylor CR
    J Histochem Cytochem; 2002 Aug; 50(8):1005-11. PubMed ID: 12133903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KRAS and BRAF mutation analysis from liquid-based cytology brushings of colorectal carcinoma in comparison with formalin-fixed, paraffin-embedded tissue.
    Spathis A; Georgoulakis J; Foukas P; Kefala M; Leventakos K; Machairas A; Panayiotides I; Karakitsos P
    Anticancer Res; 2010 Jun; 30(6):1969-75. PubMed ID: 20651341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue.
    Li G; Luo X; He J; Zhu Z; Yu G; Qin H; Zeng T; Liu Z; Wu S; Xu J; Ren-Heidenreich L
    Clin Chem Lab Med; 2011 Feb; 49(2):191-5. PubMed ID: 21118047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic acid extraction methods from fixed and paraffin-embedded tissues in cancer diagnostics.
    Bonin S; Stanta G
    Expert Rev Mol Diagn; 2013 Apr; 13(3):271-82. PubMed ID: 23570405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
    Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories.
    Feigelson HS; Goddard KA; Johnson MA; Funk KC; Rahm AK; Kauffman TL; Chitale DA; Le Marchand L; Richards CS
    BMC Res Notes; 2012 Apr; 5():196. PubMed ID: 22534075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting KRAS mutation detection in colorectal cancer tissue.
    Yun HG; Lee HJ; Kim BR; Lee JH; Lee JH; Lee MY; Kim DH; Sohn JH; Chae SW; Do IG; Do SI; Kim K
    Pathol Res Pract; 2019 May; 215(5):1071-1075. PubMed ID: 30846412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized High Quality DNA Extraction from Formalin-Fixed Paraffin-Embedded Human Atherosclerotic Lesions.
    Bauer S; Pauli J; Pelisek J
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer.
    Omolo B; Yang M; Lo FY; Schell MJ; Austin S; Howard K; Madan A; Yeatman TJ
    BMC Med Genomics; 2016 Oct; 9(1):65. PubMed ID: 27756306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.
    Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomić S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X
    Virchows Arch; 2021 May; 478(5):851-863. PubMed ID: 33170334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
    Lee S; Brophy VH; Cao J; Velez M; Hoeppner C; Soviero S; Lawrence HJ
    Virchows Arch; 2012 Feb; 460(2):141-9. PubMed ID: 22173329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase.
    Do H; Dobrovic A
    Oncotarget; 2012 May; 3(5):546-58. PubMed ID: 22643842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of first proficiency test for KRAS testing with formalin-fixed, paraffin-embedded cell lines in China.
    Zhang R; Han Y; Huang J; Ma L; Li Y; Li J
    Clin Chem Lab Med; 2014 Dec; 52(12):1851-7. PubMed ID: 24945428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovative Tumor Tissue Dissection Tool for Molecular Oncology Diagnostics.
    Javey M; Reinsch C; Feldkamp M; Siemann S; Blüher A; Woestmann C; Cai L; Tran I; May T; Havnar C; Lo AA; Hinzmann B; Heilek G; Palma JF
    J Mol Diagn; 2021 Apr; 23(4):399-406. PubMed ID: 33497835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The non-crosslinking fixative RCL2®-CS100 is compatible with both pathology diagnosis and molecular analyses.
    Boissière-Michot F; Denouël A; Boulle N; Guillaume C; Orsetti B; Lopez-Crapez E; Chateau MC; Bibeau F
    Pathol Oncol Res; 2013 Jan; 19(1):41-53. PubMed ID: 22893391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues.
    van Eijk R; van Puijenbroek M; Chhatta AR; Gupta N; Vossen RH; Lips EH; Cleton-Jansen AM; Morreau H; van Wezel T
    J Mol Diagn; 2010 Jan; 12(1):27-34. PubMed ID: 19959798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.